Xue, L., Hardman, C., Chen, W., Batty, P., Ogg, G., Erpenbeck, V., & Sandham, D. (2018). Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells. American Thoracic Society.
Style de citation Chicago (17e éd.)Xue, L., C. Hardman, W. Chen, P. Batty, G. Ogg, V. Erpenbeck, et D. Sandham. Fevipiprant, a Selective Prostaglandin D-2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells. American Thoracic Society, 2018.
Style de citation MLA (9e éd.)Xue, L., et al. Fevipiprant, a Selective Prostaglandin D-2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells. American Thoracic Society, 2018.